Literature DB >> 20165887

Treatment of Stenotrophomonas neonatal urinary tract infection with instillation of ciprofloxacin.

Mohammad Khassawneh, Wail Hayajneh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20165887     DOI: 10.1007/s00467-010-1473-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  4 in total

1.  Successful treatment of multi-resistant Stenotrophomonas maltophilia meningitis with ciprofloxacin in a pre-term infant.

Authors:  Wen-Tsung Lo; Chih-Chien Wang; Chuen-Ming Lee; Mong-Ling Chu
Journal:  Eur J Pediatr       Date:  2002-12       Impact factor: 3.183

2.  Impact of initial antimicrobial therapy in patients with bloodstream infections caused by Stenotrophomonas maltophilia.

Authors:  Gokhan Metan; Omrum Uzun
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

Review 3.  Antimicrobial therapy for Stenotrophomonas maltophilia infections.

Authors:  A C Nicodemo; J I Garcia Paez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-04       Impact factor: 3.267

4.  Safety of the new quinolones in pregnancy.

Authors:  M Berkovitch; A Pastuszak; M Gazarian; M Lewis; G Koren
Journal:  Obstet Gynecol       Date:  1994-10       Impact factor: 7.661

  4 in total
  2 in total

1.  Intranasal immunization with recombinant outer membrane protein A induces protective immune response against Stenotrophomonas maltophilia infection.

Authors:  Yan Li; Xueping Tang; Zunquan Zhao; Hui Wang; Xin Wang; Xueyi Shang; Peng Liu; Zhihua Kou; Yongqiang Jiang; Yan Li
Journal:  PLoS One       Date:  2019-04-01       Impact factor: 3.240

2.  Interplay between bladder microbiota and urinary antimicrobial peptides: mechanisms for human urinary tract infection risk and symptom severity.

Authors:  Vanessa Nienhouse; Xiang Gao; Qunfeng Dong; David E Nelson; Evelyn Toh; Kathleen McKinley; Paul Schreckenberger; Noriko Shibata; Cynthia S Fok; Elizabeth R Mueller; Linda Brubaker; Alan J Wolfe; Katherine A Radek
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.